Advertisement | | | | | TABLE OF CONTENTS
| | | | Volume 37, Issue 6 (February 2018) | | In this issue Editorial Original Articles Also new AOP | | | | | | Editorial | Top | | The importance of being earnest in post-publication review: scientific fraud and the scourges of anonymity and excuses J Stebbing and D A Sanders Oncogene 2018 37: 695-696; advance online publication, October 16, 2017; 10.1038/onc.2017.390 Full Text | | Original Articles | Top | | FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis OPEN M S Chattaragada, C Riganti, M Sassoe, M Principe, M M Santamorena, C Roux, C Curcio, A Evangelista, P Allavena, R Salvia, B Rusev, A Scarpa, P Cappello and F Novelli Oncogene 2018 37: 697-709; advance online publication, October 23, 2017; 10.1038/onc.2017.358 Abstract | Full Text | | | | Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer OPEN W Han, S Gao, D Barrett, M Ahmed, D Han, J A Macoska, H H He and C Cai Oncogene 2018 37: 710-721; advance online publication, October 23, 2017; 10.1038/onc.2017.385 Abstract | Full Text | | | | Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP) T Mitamura, S Pradeep, M McGuire, S Y Wu, S Ma, H Hatakeyama, Y A Lyons, T Hisamatsu, K Noh, A Villar-Prados, X Chen, C Ivan, C Rodriguez-Aguayo, W Hu, G Lopez-Berestein, R L Coleman and A K Sood Oncogene 2018 37: 722-731; advance online publication, October 23, 2017; 10.1038/onc.2017.348 Abstract | Full Text | | | | mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma B Holmes, A Benavides-Serrato, R S Freeman, K A Landon, T Bashir, R N Nishimura and J Gera Oncogene 2018 37: 732-743; advance online publication, October 23, 2017; 10.1038/onc.2017.360 Abstract | Full Text | | | | Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin β4/FAK/SOX2/HIF-1α signaling pathway in gastric cancer L Gan, J Meng, M Xu, M Liu, Y Qi, C Tan, Y Wang, P Zhang, W Weng, W Sheng, M Huang and Z Wang Oncogene 2018 37: 744-755; advance online publication, October 23, 2017; 10.1038/onc.2017.363 Abstract | Full Text | | | | Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis OPEN A Abbaci, H Talbot, S Saada, N Gachard, J Abraham, A Jaccard, D Bordessoule, A L Fauchais, T Naves and M O Jauberteau Oncogene 2018 37: 756-767; advance online publication, October 23, 2017; 10.1038/onc.2017.365 Abstract | Full Text | | | | SPSB3 targets SNAIL for degradation in GSK-3β phosphorylation-dependent manner and regulates metastasis Y Liu, H Zhou, R Zhu, F Ding, Y Li, X Cao and Z Liu Oncogene 2018 37: 768-776; advance online publication, October 23, 2017; 10.1038/onc.2017.370 Abstract | Full Text | | | | Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion Y Otani, T Ichikawa, K Kurozumi, S Inoue, J Ishida, T Oka, T Shimizu, Y Tomita, Y Hattori, A Uneda, Y Matsumoto, H Michiue and I Date Oncogene 2018 37: 777-786; advance online publication, October 23, 2017; 10.1038/onc.2017.373 Abstract | Full Text | | | | Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia OPEN Q Heydt, C Larrue, E Saland, S Bertoli, J-E Sarry, A Besson, S Manenti, C Joffre and V Mansat-De Mas Oncogene 2018 37: 787-797; advance online publication, October 23, 2017; 10.1038/onc.2017.376 Abstract | Full Text | | | | Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis W Luo, C Xu, J Ayello, F Dela Cruz, J M Rosenblum, S L Lessnick and M S Cairo Oncogene 2018 37: 798-809; advance online publication, October 23, 2017; 10.1038/onc.2017.378 Abstract | Full Text | | | | Plk1 phosphorylation of Numb leads to impaired DNA damage response C Shao, S-J Chien, E Farah, Z Li, N Ahmad and X Liu Oncogene 2018 37: 810-820; advance online publication, October 23, 2017; 10.1038/onc.2017.379 Abstract | Full Text | | | | RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1 S-H Chen, X Gong, Y Zhang, R D Van Horn, T Yin, L Huber, T F Burke, J Manro, P W Iversen, W Wu, S V Bhagwat, R P Beckmann, R V Tiu, S G Buchanan and S-B Peng Oncogene 2018 37: 821-832; advance online publication, October 23, 2017; 10.1038/onc.2017.384 Abstract | Full Text | | | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. | | | | |
No comments:
Post a Comment